CD38 and cancer: Likewise, concurrent overexpression of CD38 and NAMPT inhibition had synergistic effect on growth suppression in pancreatic cancer (Chini et al., 2014), suggesting a critical dependence of cancers on NAD+ that may be explored therapeutically.